NCT05134961View on ClinicalTrials.gov

Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma

CompletedOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

January 1, 1999

Primary Completion Date

August 31, 2020

Study Completion Date

September 30, 2021

Conditions
Duodenal Cancer
Interventions
PROCEDURE

Pancreaduodenectomy and possible adjuvant therapy

Adjuvant therapy was generally offered to patients with T4 or lymph node positive disease. As no national Danish guidelines exist, patients were treated based on the oncologists' preference.

Trial Locations (1)

DK-2400

Kristian Schaumburg Kiim, Copenhagen NV

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER

NCT05134961 - Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma | Biotech Hunter | Biotech Hunter